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Abstract
Presence of the human Y-chromosome in females with Turner Syndrome (TS) enhances the risk of development of
gonadoblastoma besides causing several other phenotypic abnormalities. In the present study, we have analyzed the Y
chromosome in 15 clinically diagnosed Turner Syndrome (TS) patients and detected high level of mosaicisms ranging from
45,XO:46,XY = 100:0% in 4; 45,XO:46,XY:46XX = 4:94:2 in 8; and 45,XO:46,XY:46XX = 50:30:20 cells in 3 TS patients, unlike
previous reports showing 5–8% cells with Y- material. Also, no ring, marker or di-centric Y was observed in any of the cases.
Of the two TS patients having intact Y chromosome in .85% cells, one was exceptionally tall. Both the patients were
positive for SRY, DAZ, CDY1, DBY, UTY and AZFa, b and c specific STSs. Real Time PCR and FISH demonstrated tandem
duplication/multiplication of the SRY and DAZ genes. At sequence level, the SRY was normal in 8 TS patients while the
remaining 7 showed either absence of this gene or known and novel mutations within and outside of the HMG box. SNV/
SFV analysis showed normal four copies of the DAZ genes in these 8 patients. All the TS patients showed aplastic uterus
with no ovaries and no symptom of gonadoblastoma. Present study demonstrates new types of polymorphisms indicating
that no two TS patients have identical genotype-phenotype. Thus, a comprehensive analysis of more number of samples is
warranted to uncover consensus on the loci affected, to be able to use them as potential diagnostic markers.
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Introduction
Turner Syndrome (TS), the common genetic abnormalities
affecting ,1 in 1500–2000 live female births [1–3], is suggested to
be due to absence of the second X chromosome in part or full [3–
4]. However, in,3–6% cells, the second sex chromosome is Y [5–
6] that often triggers development of gonadoblastoma [7]. The Y
chromosome in Turner patients is structurally abnormal showing
deletions, inversions, dicentrics and ring forms [8–9] and becomes
unstable resulting in 45/XO karyotype. Chromosomal constitu-
tion influences phenotypic sex and 45, XO cell line is frequently
detected in males with gonadal dysgenesis in addition to TS
patients [10–11]. It is largely believed that no two TS patients are
identical with respect to the number of Y bearing cells or Y-linked
loci. Moreover, this mosaicism varies across the tissues and thus
accurate interpretation depends upon the number of cells analyzed
and tissues selected [12–13]. The phenotypic sex is under the
influence of Y chromosome and expression of Y linked loci in
gonads [14–15]. In several instances, gonadectomy is conducted
due to increased risks of gonadoblastoma [16]. However, actual
distribution of the Y chromosome in tissues of the TS patients and
its role remain a murky proposition.
Present study was conducted to investigate molecular alterations
in the Y-linked loci in 15 clinically diagnosed TS patients. We
detected large scale Y chromosome mosaicism ranging from pure
45/XO conceptus to ,90% cells positive for an intact Y
chromosome and XXX, XYY, XXY constitutions. Further,
several Turners patients showed tandemly arranged multiple
copies of the SRY and DAZ genes in addition to known and novel
SRY mutations within and 59/39 regions of the HMG box.
Results
Turner Karyotypes and the Y chromosome
TS patients analyzed were in the age group of 14–25 yrs.
Presence of Y chromosome detected with G-Banding was
confirmed by FISH with Y specific probes SRY, 46A6 (DAZ) and
336F2 (gr/gr AZFc amplicons). Patients showed two extreme
karyotypes, ones with .85% cells harboring Y chromosome (AT1
and AT15) and others with almost negligible presence of the Y
chromosome (AT4, AT5, AT6 and AT7) (Table 1). Marker, ring
or dicentrics Y chromosome was not observed in any of the
patients. Clinically, all the TS patients had webbed neck, shield
like chest and other characteristic features (Table 1) but no
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Figure 1. Fluorescence in-situ hybridization (FISH) using LSI SRY probe from VYSIS (which binds simultaneously to the SRY gene and
centromere of the X chromosome) within the interphase nuclei and metaphase chromosomes of Turner AT1. (A i–iv) shows presence of both X
(green dot) and Y (red dot) chromosomes in the interphase nuclei. Note structurally normal Y chromosome and absence of ring or dicentric one in
(Bi) and (Ci) where the SRY gene is localized on the Yp. Some cells showed absence of the X chromosome, denoted by pink arrows (Bii) and (Cii).
The classical Turner karyotypes (45, XO) are shown by yellow arrows. Some cells showed 47, XYY (Civ). (D), Cells without Y but variable numbers of X
chromosome ranging from 1 (45, XO) to 2 (46, XX) were also detected. Only representative cells with different karyotypes are shown here. Single
localized signal of the SRY gene (copy number 16) in AT1 suggests tandem duplication of this gene.
doi:10.1371/journal.pone.0003796.g001
Figure 2. FISH with interphase nuclei and metaphase chromosomes of a Turner patient (AT4) with LSI-SRY probe. Note absence of the
SRY signals in all the cells. No detectable Y chromosome at the level of PCR or G-banding was detected in this patient. The alterations detected in the
number of X-Chromosomes are indicated by arrows. Pink arrows show cells with three X-Chromosomes (47, XXX) and the yellow ones highlights the
cells with a single X-Chromosome (45, XO). Remaining interphases showed two X-Chromosomes (46, XX). Analysis of metaphase chromosomes (i–ii)
further substantiated absence of the Y-chromosome. This is in contrast to Turner AT1 where .80% cells harbored Y-chromosome.
doi:10.1371/journal.pone.0003796.g002
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symptoms/trace of gonadoblastoma. Only one Turner (AT9)
showed dysgenic testis which was removed surgically. One TS
patient (AT15) was exceptionally tall with a normal female
phenotype, but with clinical features similar to that of the
Turners’. In addition to normal mosaic karyotypes, two Turners’,
AT1 and AT15 also showed another cell lines with 47, XYY, or
47, XXY chromosomal constitutions (Figure 1). Pure XO
conceptus was also detected in some Turners, showing two, one
or no signal for X chromosome but none at all for the Y
chromosome (Figure 2).
Structural integrity of Y the chromosome
Structural integrity of the Y chromosome was assessed by
routine STS mapping. In TS patients with more than 40% cells
positive for Y chromosome, most of the STS’s used were positive
(Figure 3). STS mapping nullified any event of the gr/gr or b1/b3
major deletion phenotypes [17]. STSs lying in the crucial regions
like DAZ gene, HERV sequences, AZF boundaries and other
crucial genes were found to be intact except few randomly
scattered microdeletions (Figure 4).
Tandem duplication of the SRY and DAZ genes
Turners were assessed for the possible duplication of two
candidate genes DAZ and SRY using TaqMan chemistry and Real
Time PCR. In most of the patients, DCt (Ct SRY/DAZ – Ct
RNAseP easy) values observed were unexpected. In case of single
copy SRY and 4 copy DAZ genes in a normal male, DCt values
observed are 1 and 21, respectively [18]. Unexpectedly, DCt for
SRY and DAZ gene were .1 in case of TS patients (Figures 5 and
6, Table 2). This is possible only if the copies are less than one,
which technically can not be true. The reason behind this was
presence of RNAseP gene in all the cells but that of Y chromosome
in a small cell population. Even with this mosaicism, few TS
patients showed,2 to 3 rounds of duplication of the SRY and DAZ
genes (Table 2). FISH conducted for SRY and DAZ genes showed
single localized signal in all the TS patients. This correlated with
the events of tandem duplications (See Figures 1 and 7).
Fate of AZFc region in Turners
Cosmid probes for DAZ genes and BAC probe used for FISH
corresponding to green amplicon demonstrated yet another
Figure 3. Representative gels showing STS mapping of the Y chromosomes in TS patients. STSs used are given on the right and sample
IDs on top. The IDs ‘AT’ are Turners and their details are given in the table 1. A10 and A10g represent blood and semen DNA samples, respectively,
from a single azoospermic male. HF denotes human female DNA sample. b-actin primers were used to normalize the quality and quantity of DNA
used as template in PCR. Note presence of most of the STSs in Turners AT1 and AT15. Some STSs were positive in case of Turner AT13 as well but
owing to non-availability of the fresh blood, the FISH experiments could not be conducted (see Tables 1 and 2 for details of the Turner patients).
doi:10.1371/journal.pone.0003796.g003
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mosaicism in TS patients. Probe C uncovered expected 2 to a
single, widely spaced 3, or no FISH signals. Some cells showed two
signals of which one was with higher intensity compared to that of
the other suggesting unilocus duplication of the DAZ genes [18].
In the dual color FISH, probe A showed expected 2 or a single
signal in most of the cells but probe C again showed multiple
signals in certain cell population. Ideally, the signals for probe A
and B should overlap owing to their vicinity which was not
observed in any of the Turner Patients. This important
observation has been explained in a separate report. Significantly,
probes C and D uncovered unexpected widely spaced 3 to
multiple signals (Figure 7).
SRY mutations
SRY was taken as a candidate gene since the same has been well
characterized. This gene was sequenced from all the TS patients
who showed positive PCR amplification. All three Turners’
positive for SRY gene showed normal sequence except a few
unclear point nucleotide changes. Mostly, the nucleotide changes
were silent except a few affecting the protein sequence. The in-silico
translation and sequence comparisons showed few well defined
amino acid changes upstream, within and down stream of the
HMG box. Details of the nucleotide changes of SRY gene observed
in Turner AT1 are given in figure S2 and corresponding amino
acid changes in figure 8. Father of this patient showed a single
amino acid change (Figure 9) suggesting that the changes in AT1
were de novo, and not inherited from the father.
Discussion
Turner Syndrome (TS) is globally acknowledged and well
defined genetic anomaly, postulated to be an effect of the absence
of genes located on the second sex chromosome. However, it is not
clear as to how many loci/genes are affected in TS nor do we
know whether the abnormal genes/loci are cause or effects.
Similarly, there is no information on the type of Y linked genes/
loci affected in somatic tissue and gonad of a Turner Patient.
Primary focus of the present study was to analyze the fate of the
human Y chromosome and its linked loci/genes in TS patients
with respect to their possible copy number variation and new type
of mutations. This study was undertaken with an ultimate view to
uncover consensus changes in the genes/loci to use the resultant
information for molecular diagnosis. Extreme mosaicism in terms
of the presence or absence of Y chromosome with almost similar
hormonal profile and characteristic Turners’ features was found to
be most astonishing. This suggests that genes involved in control
and regulation of hormonal profiles were not affected. Clinically,
most accepted karyotype of TS is 45/XO. However, we detected
.85% cells harboring intact Y chromosome (46, XY karyotype) in
some phenotypically females TS patients. Despite such a large
percentage of Y bearing cells, these patients did not represent
Swyer syndrome (Gonadal dysgenesis). We hypothesize that in
addition to sex chromosomes, there may be several other factors
including autosomal genes, responsible for TS phenotype. Other
significant part of this study was the absence of dicentrics, marker
or ring Y chromosomes in any of the 15 TS patients analyzed
though these features were reported to be common in Turner
mosaics [16]. Instance(s) of pure XO conceptus cannot be
demonstrated unequivocally since chromosome analysis does not
uncover the lowest level of Y chromosome mosaicism in
lymphocytes or any other tissues. In order to resolve all the
ambiguous cases, we used Real Time PCR to monitor copy
number status of the genes/loci linked to Y chromosome. This is
true also for the other patients suffering from sex chromosome
related anomalies such as Turners, Klinefelters, azoospermic and
oligospermic ones. It has already been demonstrated that level of
mosaicism varies with higher percentage of Y bearing cells in other
tissues/organs than that in blood [16]. Gonadal tissue though most
important for such analyses is not feasible to be analyzed. Thus,
analysis of the blood may fail to allow accessing the actual levels of
mosaicism and its correlation with phenotypic sex in TS cases.
Copy number analyses demonstrated multiple rounds of tandem
duplications wherein two Turners AT1 and AT15 were found to
harbor 16 and 8 copies of the SRY gene, respectively (Table 2).
Based on the karyotype, it is hypothesized that there are varying
number of SRY genes per cell leading to 16 and 8 copies. Further,
Figure 4. Analysis of the AZFa region of the Y chromosome in Turner Patients for possible HERV mediated recombination. (A) AZFa
region of the human Y chromosome indicated as horizontal bar with centromere towards left and Yq to right. Various STS markers used for the
analysis of the AZFa region and the candidate genes (DBY, UTY, USP9Y) are mentioned in the figure. The positions of provirus element A and B are
shown by red dotted lines. (B) Detailed structure of the provirus A and B. Note the LINE insertion in provirus B. Various STS markers used to assess
recombination events involving provirus elements are also indicated. (C) Results of the provirus (HERV) mapping of the Turner’s syndrome. It may be
noted that none of the males showed characteristic patterns of HERV mediated recombination leading to the AZFa deletion or duplication.
doi:10.1371/journal.pone.0003796.g004
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two copies of the SRY gene detected in father of AT1 suggested
that this patient (AT1) did not inherit all the 16 copies instead the
same was the result of multiple rounds of tandem duplications.
Although no direct evidence is available, these observations
suggest that non-disjunction of the Y chromosome and duplica-
tions of the linked genes are two independent events. As
mentioned earlier, total number of genes/loci affected in case of
TS is not known. In addition, involvement of the autosomal genes,
their possible up-, down- regulation or genetic imprinting remains
allusive in such patients. It would therefore be of relevance if
expression level of Y linked genes and possibly autosomal ones are
assessed in TS with or without cytogenetically detectable Y
chromosome or its mosaicism. Of all the autosomal genes, those that
are candidates for testicular functions and hormonal profiles may
prove to be attractive targets. Similarly, in-depth mutational analysis
of all the candidate genes involved in testicular functions in addition
to Y linked loci would also prove to be equally informative.
Information on this line is envisaged to be of relevance not only for
molecular diagnosis of TS but also for prenatal prognosis and
management of clinical cases on routine basis.
Figure 5. Real Time PCR plots for SRY in Turner patients. (A) Due to very low number or absence of cells harboring Y chromosome in Turners’
AT2 to AT12, the Ct for SRY remained undetermined and thus copy number of the same could not be calculated. (B) Real Time PCR plot of a normal
male with DCt = 1 corresponding to copies of the SRY=1. (C) and (D) represent plots for additional mosaicisms in the context of percentage of the Y
chromosome (and thus for the SRY gene) in Turner AT13. The DCt values (2 or 4) are unexpected, suggesting that percentage of cells harboring SRY is
less compared to the ones harboring RNaseP gene. In Turners AT1 and AT15, DCt23 and22 respectively, were observed resulting in 16 and 8 copies
of the SRY gene (not shown).
doi:10.1371/journal.pone.0003796.g005
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Conclusions
Present study is an attempt to analyze status of the human Y
chromosome in patients with Turner Syndrome. Clinical Turner
symptoms were common both in females with negligible presence
of Y (45, XO) and the ones carrying Y in.85% cells (46, XY). We
also infer that in addition to +/2 mosaicism of the Y
chromosome, Turners may harbor copy number polymorphism
of several Y linked genes and possibly that of autosomes.
Notwithstanding a great deal of information available in the
literature, it is still not proven whether the Y mosaicism observed is
a cause or consequence of Turner Syndrome.
Materials and Methods
Sample collection and isolation of DNA
Blood samples from all the TS patients were collected from J.N.
Medical College, Aligarh Muslim University, Aligarh, India, with
the informed consent of patients following strictly the guidelines of
Figure 6. Real Time PCR plots for copy number calculation of the DAZ genes in Turner patients. (A) and (B) Similar to the SRY, lack of Y
chromosome in some Turners resulted a increase in Ct values of DAZ genes. (C) Representative plot showing 8 copies instead of 4 of the DAZ gene in
Turners Patients. (D) Representative plot showing normal 4 copies of the DAZ genes with DCt =21.
doi:10.1371/journal.pone.0003796.g006
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the Institute’s Ethical and Biosafety Committees. All the patients,
except two, were phenotypically females with short stature and
webbed neck. TS patients had shield like chest, reproductive
sterility and primary amenorrhea (Table 1). DNA isolation was
done from the blood samples using standard protocols [19].
Several DNA samples p2b/14, p216c, p4, (p20, p21 Swyer),
p65971, p65972, p17698, p6697, p65975, (p75973 and 74,
cryptorchidism), p65975 were available from our previous study
that were also included [20].
Majority of the Turner patients were illiterate, therefore, their oral
consent were obtained. This was facilitated by a recognized local
clinician who was also known to them. From the literate people,
written consents were obtained following which Institute’s Ethical
Committee accorded its due clearance. After Institute’s Ethical
Clearance, no additional approval regarding a particular gene
sequence/gene variant was required for publication of the data.
Estimation of hormonal levels
Level of FSH, TSH, LH and PRL was estimated taking 100 ml
serum obtained from each sample by radioimmunoassay using
commercial kits from Bhaba Atomic Research Center, Bombay
according to supplier’s instructions.
Detection of various Y linked loci by PCR
PCR was performed to amplify SRY, CDY, DAZ, XKRY, DBY,
UTY, CDY2 genes and several STS markers. The amplified
product of SRY gene from the TS patients was sequenced for its
mutational analysis. The DAZ genes were assessed for the presence
of sequence family variants [18] which was confirmed by
sequencing of the PCR products. In addition to direct sequencing,
SRY fragments were also sequenced in multiples by cloning into
pGEMT-easy vector (Promega).
Structural analysis of crucial Y regions was done by selected
STSs employing single and multiplex PCRs. The absence of a
particular STS was confirmed by repeating the PCR reactions
thrice followed by Southern hybridization using amplified PCR
product as probe from the normal male. The AZFa region was also
assessed for possible provirus mediated recombination leading to
duplication or deletion [21].
Copy number assessment of the SRY and DAZ genes
SRY and DAZ were chosen as candidate genes for their copy
number status. Copy number of was calculated using Real Time
PCR and TaqMan/SYBR green assays following procedures
described earlier [18,22].
Table 2. Copy number polymorphism of the SRY and DAZ genes in the Turner Syndrome patients.
ID KARYOTYPE SRY DAZ
DCt COPIES DCt COPIES
p2B 45,XO 46,XX 46,XY 1–3 Mosaic 21–0 Mosaic
p2C NA 0–1 1 21 4
p4 45,XO 46,XX 46,XY 5–10 mosaic 0–1 Mosaic
p65971 46,XX 46,XY 46,XXXp 23 16 22 8
F- p65971 NA 0 2 21 4
p6697 NA #Undt 0 Undt 0
p65972 NA 23 16 20.5–(21) Mosaic
p65975 NA 22 8 21 4
p17698 NA Undt 0 Undt 0
AT1 46,XX (10):46,XY (75):45,XO (5):47,XXY (2):47,XYY(3) 23 16 21–(22) Mosaic
AT2 46,XX (77): 46,XY (6):45,XO (14): 47,XXX (3) Undt 0 Undt 0
AT3 46,XX (2):46,XY (3):45,XO (95) Undt 0 Undt 0
AT4 46,XX (0):46,XY (0):45,XO (100) Undt 0 Undt 0
AT5 46,XX (5):46,XY (0):45,XO (95) Undt 0 Undt 0
AT6 46,XX (0):46,XY (0):45,XO (100) Undt 0 Undt 0
AT7 46,XX (5):46,XY (0):45,XO (95) Undt 0 Undt 0
AT8 46,XX (5):46,XY (3):45,XO (92) Undt 0 Undt 0
AT9 46,XX (5):46,XY (5):45,XO (90) Undt 0 Undt 0
AT10 46,XX (5):46,XY (3):45,XO (92) Undt 0 Undt 0
AT11 46, XX (2):46, XY (2):45, XO (96) Undt 0 Undt 0
AT12 46, XX (5):46, XY (3):45, XO (92) Undt 0 Undt 0
AT13 46, XX (40):46, XY (30):45, XO (20) Undt 0 Undt 0
AT14 46,XX (5):46,XY (3):45,XO (92) Undt 0 Undt 0
AT15 46,XX (5):46,XY (80):45,XO (5):47,XXY (2):47,XYY(3) 22 8 21–(0) Mosaic
NM 46, XY 1 1 21 4
NF 46XX Undt 0 Undt 0
Numbers in parenthesis under karyotype denote percentage of the cells with the particular chromosomal constitution. Numbers in parenthesis under karyotype denote
percentage of the cells with the particular chromosomal constitution. All the karyotypes were confirmed analyzing ,400 metaphase chromosome sets per individual. #
Undt’’ is for undetermined owing to high level of mosaicism.
doi:10.1371/journal.pone.0003796.t002
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Figure 7. FISH for DAZ genes in Turner Patient AT1. The A, B, C and D denote DAZ probes (supplementary figure 1) and, tr and fl are for texas
red and fluorescein labels, respectively. (A) Note presence of 2 expected signals or a single one owing to overlap in several cells. Some cells lacked
signals (v) and others showed 3 signals in place of 2 (vi). (B) Dual probe FISH with DAZ probe A in red and B in green. Expected overlap of the probes
A and B was not observed in most of the cells except a few (iii). Localized DAZ signals detected by FISH and multiple copies by Real Time PCR
highlight the events of tandem duplication. (C) Analysis of the AZFc green amplicons in Turners. Note the presence of all three green amplicons
observed in the form of 3 well separated signals. Few cells even showed 2 signals where 1 was of higher intensity compared to that detected in
others (vi, vii). This suggests a possible sequence re-modulation or reorganization of the AZFc in some percentage of cells in TS patients. The
conclusions were based following analyses of 400 metaphase/interphase cells from each Turner Patient.
doi:10.1371/journal.pone.0003796.g007
Figure 8. Amino acid changes corresponding to nucleotide sequence of the SRY gene in Turners AT1 and AT15. Note the amino acid
changes within, upstream and downstream regions of the HMG box which is underlined. Most of these changes detected in the present study were
not described earlier.
doi:10.1371/journal.pone.0003796.g008
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Chromosome preparation and fluorescence in-situ
hybridization (FISH)
Approximately, 400 ml of whole blood was cultured for
chromosome preparation following standard protocols [22]. LSI
SRY (Cat 32-191007) DNA FISH probe for SRY/CEP X was
purchased from VYSIS (Illinois, USA). FISH probes for DAZ
included Cosmids 18E8 for 59 DAZ, Probe A; 46A6 for 39DAZ,
probe B and 63C9 containing exons 2 through 11, Probe C [23].
For AZFc green amplicon, FISH probe used was BAC RP11-
336F2, probe D. The cosmid probes were purchased from Gene
service, UK (www.geneservice.co.uk/home) and BAC from
Children’s Hospital Oakland Research Institute (CHORI). Details
of the clones are given in Figure S1. FISH was conducted
following standard protocol [18,22]. Biotynilated anti-fluorescein
and anti-texas red antibodies coupled with fluorescein and texas
red avidin DCS (Vector Labs) were used in the dual probe FISH
experiments. Over 400 interphases/metaphases per individual
were analyzed for the presence/absence of the Y chromosome.
Supporting Information
Figure S1 Details of the FISH probes used for the DAZ genes
are listed in the table
Found at: doi:10.1371/journal.pone.0003796.s001 (11.64 MB
TIF)
Figure S2 Nucleotide sequence polymorphism of the SRY gene
in Turners AT1 and AT15.
Found at: doi:10.1371/journal.pone.0003796.s002 (14.71 MB
TIF)
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